Factors associated with the incidence of revision total knee arthroplasty in Korea between 2007 and 2012: an analysis of the National Claim Registry

BMC Musculoskeletal Disorders

Seung-Baik Kang²  Jin Hwa Jeong²  Suk-Hyun Cho¹  Chong Bum Chang²  Chang Ho Shin² 

[1] Review and Assessment Committee, Health Insurance Review and Assessment Service, Seoul, Republic of Korea;Department of Orthopaedic Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, 20, Boramae-ro 5-gil, Seoul 156-707, Dongjak-gu, Republic of Korea

关键词: Revision total knee arthroplasty;    National Claim Registry;    Manufacturer volume;    Incidence;    Hospital volume;    Gender;    Age;   

Others  :  1232702
DOI  :  10.1186/s12891-015-0781-1

 received in 2015-07-21, accepted in 2015-10-17,  发布年份 2015

【 摘 要 】

Background

The number of revision total knee arthroplasties (TKAs) in Asian countries is projected to increase with the rapid growth of primary TKA. We investigated the factors associated with the incidence of revision TKA using a nationally representative database.

Methods

Data collected by the Health Insurance Review Agency of Korea, from 260,068 TKA patients between 2007 and 2012, were used to estimate the incidence rate and cumulative incidence of revision TKA according to age, gender, and hospital TKA and prosthesis manufacturer volume. Age, hospital, and manufacturer volume were categorized into three groups. The incidence rates and cumulative incidences of revision TKA were computed by combining age and gender, and by combining hospital and prosthesis manufacturer volume.

Results

Incidence rates per 100,000 person-years were as follows: 1) by age: < 65 years, 447.2; 65–74 years, 363.7; ≥ 75 years, 270.9, 2) by gender: male, 537.8; female, 346.1; 3) by hospital volume (procedures/year): < 20, 536.9; 20–199, 432.3; ≥ 200, 300.1; and 4) by manufacturer volume (prostheses/year): < 1500, 772.3; 1500–3999, 453.9; ≥ 4000, 345.6. The revision TKA incidence rate in young males was significantly higher compared to that in elderly females. The difference in cumulative incidence, between hospitals with an annual volume of < 20 procedures and those with a volume of 20–199 procedures, was reduced for manufacturers with an annual volume of ≥ 4000. Similarly, the difference in cumulative incidence between manufacturers with an annual volume of <1500 prostheses and those with a volume of 1500–3999 prostheses was reduced in hospitals with an annual volume of ≥ 200.

Conclusion

Revision TKA incidence varied according to age, gender, and hospital and manufacturer volume. This data could inform clinical decisions and healthcare strategies.

【 授权许可】

   
2015 Shin et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Figure 7.

Fig. 5.

Fig. 6.

Fig. 7.

【 参考文献 】

• [1]Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following tricompartmental total knee replacement. A meta-analysis. JAMA. 1994; 271(17):1349-1357.
• [2]Heck DA, Robinson RL, Partridge CM, Lubitz RM, Freund DA. Patient outcomes after knee replacement. Clin Orthop Relat Res. 1998; 356:93-110.
• [3]Lavernia CJ, Guzman JF, Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res. 1997; 345:134-139.
• [4]Kasahara Y, Majima T, Kimura S, Nishiike O, Uchida J. What are the causes of revision total knee arthroplasty in Japan? Clin Orthop Relat Res. 2013; 471(5):1533-1538.
• [5]Koh IJ, Kim TK, Chang CB, Cho HJ, In Y. Trends in use of total knee arthroplasty in Korea from 2001 to 2010. Clin Orthop Relat Res. 2013; 471(5):1441-1450.
• [6]Wei MH, Lin YL, Shi HY, Chiu HC. Effects of provider patient volume and comorbidity on clinical and economic outcomes for total knee arthroplasty: a population-based study. J Arthroplasty. 2010; 25(6):906-912.
• [7]Yan CH, Chiu KY, Ng FY. Total knee arthroplasty for primary knee osteoarthritis: changing pattern over the past 10 years. Hong Kong Med J. 2011; 17(1):20-25.
• [8]Bansal A, Khatib ON, Zuckerman JD. Revision total joint arthroplasty: the epidemiology of 63,140 cases in New York State. J Arthroplasty. 2014; 29(1):23-27.
• [9]Dy CJ, Marx RG, Bozic KJ, Pan TJ, Padgett DE, Lyman S. Risk factors for revision within 10 years of total knee arthroplasty. Clin Orthop Relat Res. 2014; 472(4):1198-1207.
• [10]Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP et al.. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010; 468(1):45-51.
• [11]Burns AW, Bourne RB, Chesworth BM, MacDonald SJ, Rorabeck CH. Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res. 2006; 446:29-33.
• [12]Kim S. Changes in surgical loads and economic burden of hip and knee replacements in the US: 1997–2004. Arthritis Rheum. 2008; 59(4):481-488.
• [13]Koh IJ, Cho WS, Choi NY, Kim TK. Causes, risk factors, and trends in failures after TKA in Korea over the past 5 years: a multicenter study. Clin Orthop Relat Res. 2014; 472(1):316-326.
• [14]Pabinger C, Berghold A, Boehler N, Labek G. Revision rates after knee replacement. Cumulative results from worldwide clinical studies versus joint registers. Osteoarthritis Cartilage. 2013; 21(2):263-268.
• [15]Rand JA, Trousdale RT, Ilstrup DM, Harmsen WS. Factors affecting the durability of primary total knee prostheses. J Bone Joint Surg Am. 2003; 85-A(2):259-265.
• [16]Hervey SL, Purves HR, Guller U, Toth AP, Vail TP, Pietrobon R. Provider Volume of Total Knee Arthroplasties and Patient Outcomes in the HCUP-Nationwide Inpatient Sample. J Bone Joint Surg Am. 2003; 85-A(9):1775-1783.
• [17]Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am. 2004; 86-A(9):1909-1916.
• [18]Paterson JM, Williams JI, Kreder HJ, Mahomed NN, Gunraj N, Wang X et al.. Provider volumes and early outcomes of primary total joint replacement in Ontario. Can J Surg. 2010; 53(3):175-183.
• [19]Badawy M, Espehaug B, Indrekvam K, Engesaeter LB, Havelin LI, Furnes O. Influence of hospital volume on revision rate after total knee arthroplasty with cement. J Bone Joint Surg Am. 2013; 95(18):e131.
• [20]Clements WJ, Miller L, Whitehouse SL, Graves SE, Ryan P, Crawford RW. Early outcomes of patella resurfacing in total knee arthroplasty. Acta Orthop. 2010; 81(1):108-113.
• [21]Manley M, Ong K, Lau E, Kurtz SM. Total knee arthroplasty survivorship in the United States Medicare population: effect of hospital and surgeon procedure volume. J Arthroplasty. 2009; 24(7):1061-1067.
• [22]Robertsson O, W-Dahl A. The Risk of Revision After TKA Is Affected by Previous HTO or UKA. Clin Orthop Relat Res. 2015; 473(1):90-93.
• [23]Kim HA, Koh SH, Lee B, Kim IJ, Seo YI, Song YW et al.. Low rate of total hip replacement as reflected by a low prevalence of hip osteoarthritis in South Korea. Osteoarthritis Cartilage. 2008; 16(12):1572-1575.
• [24]Singh JA, Kwoh CK, Boudreau RM, Lee GC, Ibrahim SA. Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database. Arthritis Rheum. 2011; 63(8):2531-2539.
• [25]Soohoo NF, Zingmond DS, Lieberman JR, Ko CY. Primary total knee arthroplasty in California 1991 to 2001: does hospital volume affect outcomes? J Arthroplasty. 2006; 21(2):199-205.
• [26]Mitsuyasu S, Hagihara A, Horiguchi H, Nobutomo K. Relationship between total arthroplasty case volume and patient outcome in an acute care payment system in Japan. J Arthroplasty. 2006; 21(5):656-663.
• [27]Lim S, Koo BK, Lee EJ, Park JH, Kim MH, Shin KH et al.. Incidence of hip fractures in Korea. J Bone Miner Metab. 2008; 26(4):400-405.
• [28]Yoon HK, Park C, Jang S, Jang S, Lee YK, Ha YC. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26(8):1087-1092.
• [29]Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA et al.. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med. 2009; 169(12):1113-1121.
• [30]McCalden RW, Robert CE, Howard JL, Naudie DD, McAuley JP, MacDonald SJ. Comparison of outcomes and survivorship between patients of different age groups following TKA. J Arthroplasty. 2013; 28(8 Suppl):83-86.
• [31]Dalury DF, Mason JB, Murphy JA, Adams MJ. Analysis of the outcome in male and female patients using a unisex total knee replacement system. J Bone Joint Surg (Br). 2009; 91(3):357-360.
• [32]Khatod M, Inacio M, Paxton EW, Bini SA, Namba RS, Burchette RJ et al.. Knee replacement: epidemiology, outcomes, and trends in Southern California: 17,080 replacements from 1995 through 2004. Acta Orthop. 2008; 79(6):812-819.
• [33]MacDonald SJ, Charron KD, Bourne RB, Naudie DD, McCalden RW, Rorabeck CH. The John Insall Award: gender-specific total knee replacement: prospectively collected clinical outcomes. Clin Orthop Relat Res. 2008; 466(11):2612-2616.
• [34]O'Connor MI. Implant survival, knee function, and pain relief after TKA: are there differences between men and women? Clin Orthop Relat Res. 2011; 469(7):1846-1851.
• [35]Singh JA, Kwoh CK, Richardson D, Chen W, Ibrahim SA. Gender and surgical outcomes and mortality after primary total knee arthroplasty: a risk-adjusted analysis. Arthritis Care Res (Hoboken). 2013; 65(7):1095-1102.
• [36]Kreder HJ, Grosso P, Williams JI, Jaglal S, Axcell T, Wal EK et al.. Provider volume and other predictors of outcome after total knee arthroplasty: a population study in Ontario. Can J Surg. 2003; 46(1):15-22.
• [37]Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991–2010. JAMA. 2012; 308(12):1227-1236.